Skip to content
Subscriber Only

DNA Startup Oxford Nanopore Wins Oracle Backing for Upcoming IPO

  • Company’s offering will also include a sale of existing shares
  • IPO comes amid a global listing boom fueled by strong markets
Updated on

Want the lowdown on European markets? In your inbox before the open, every day. Sign up here.

DNA-sequencing company Oxford Nanopore Technologies Ltd., whose technology is used to identify variants of Covid-19, is looking to raise 300 million pounds ($415 million), with Oracle Corp. agreeing to be a cornerstone investor.